ABMD
Price:
$381.02
Market Cap:
$17.18B
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flo...[Read more]
Industry
Medical - Devices
IPO Date
1987-07-29
Stock Exchange
NASDAQ
Ticker
ABMD
According to Abiomed, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 65.36. This represents a change of 13.78% compared to the average of 57.44 of the last 4 quarters.
The mean historical PE Ratio of Abiomed, Inc. over the last ten years is 79.04. The current 65.36 PE Ratio has changed 8.17% with respect to the historical average. Over the past ten years (40 quarters), ABMD's PE Ratio was at its highest in in the September 2013 quarter at 176.65. The PE Ratio was at its lowest in in the June 2014 quarter at -147.33.
Average
79.04
Median
83.83
Minimum
25.58
Maximum
139.34
Discovering the peaks and valleys of Abiomed, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 310.02%
Maximum Annual PE Ratio = 139.34
Minimum Annual Increase = -91.63%
Minimum Annual PE Ratio = 25.58
Year | PE Ratio | Change |
---|---|---|
2022 | 110.28 | 72.86% |
2021 | 63.80 | 97.48% |
2020 | 32.30 | -32.92% |
2019 | 48.16 | -57.95% |
2018 | 114.54 | 10.27% |
2017 | 103.87 | -0.97% |
2016 | 104.89 | 310.02% |
2015 | 25.58 | -81.64% |
2014 | 139.34 | 192.27% |
2013 | 47.67 | -91.63% |
The current PE Ratio of Abiomed, Inc. (ABMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
68.79
5-year avg
73.82
10-year avg
79.04
Abiomed, Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abiomed, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abiomed, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Abiomed, Inc.'s PE Ratio?
How is the PE Ratio calculated for Abiomed, Inc. (ABMD)?
What is the highest PE Ratio for Abiomed, Inc. (ABMD)?
What is the 3-year average PE Ratio for Abiomed, Inc. (ABMD)?
What is the 5-year average PE Ratio for Abiomed, Inc. (ABMD)?
How does the current PE Ratio for Abiomed, Inc. (ABMD) compare to its historical average?